264 related articles for article (PubMed ID: 15841255)
1. Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment.
Irwin M; Pike J; Oxman M
Evid Based Complement Alternat Med; 2004 Dec; 1(3):223-232. PubMed ID: 15841255
[TBL] [Abstract][Full Text] [Related]
2. Effects of a behavioral intervention, Tai Chi Chih, on varicella-zoster virus specific immunity and health functioning in older adults.
Irwin MR; Pike JL; Cole JC; Oxman MN
Psychosom Med; 2003; 65(5):824-30. PubMed ID: 14508027
[TBL] [Abstract][Full Text] [Related]
3. Major depressive disorder and immunity to varicella-zoster virus in the elderly.
Irwin MR; Levin MJ; Carrillo C; Olmstead R; Lucko A; Lang N; Caulfield MJ; Weinberg A; Chan IS; Clair J; Smith JG; Marchese RD; Williams HM; Beck DJ; McCook PT; Johnson G; Oxman MN
Brain Behav Immun; 2011 May; 25(4):759-66. PubMed ID: 21329753
[TBL] [Abstract][Full Text] [Related]
4. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
5. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi.
Irwin MR; Olmstead R; Oxman MN
J Am Geriatr Soc; 2007 Apr; 55(4):511-7. PubMed ID: 17397428
[TBL] [Abstract][Full Text] [Related]
6. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.
Irwin MR; Levin MJ; Laudenslager ML; Olmstead R; Lucko A; Lang N; Carrillo C; Stanley HA; Caulfield MJ; Weinberg A; Chan IS; Clair J; Smith JG; Marchese RD; Williams HM; Beck DJ; McCook PT; Zhang JH; Johnson G; Oxman MN
Clin Infect Dis; 2013 Apr; 56(8):1085-93. PubMed ID: 23413415
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
8. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.
Weinberg A; Zhang JH; Oxman MN; Johnson GR; Hayward AR; Caulfield MJ; Irwin MR; Clair J; Smith JG; Stanley H; Marchese RD; Harbecke R; Williams HM; Chan IS; Arbeit RD; Gershon AA; Schödel F; Morrison VA; Kauffman CA; Straus SE; Schmader KE; Davis LE; Levin MJ;
J Infect Dis; 2009 Oct; 200(7):1068-77. PubMed ID: 19712037
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
[TBL] [Abstract][Full Text] [Related]
10. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunity to varicella-zoster virus in patients with major depression.
Irwin M; Costlow C; Williams H; Artin KH; Chan CY; Stinson DL; Levin MJ; Hayward AR; Oxman MN
J Infect Dis; 1998 Nov; 178 Suppl 1():S104-8. PubMed ID: 9852986
[TBL] [Abstract][Full Text] [Related]
12. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4
Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H
Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406
[TBL] [Abstract][Full Text] [Related]
13. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
15. Animal models of varicella zoster virus infection.
Haberthur K; Messaoudi I
Pathogens; 2013 May; 2(2):364-82. PubMed ID: 25437040
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster (shingles) and postherpetic neuralgia.
Sampathkumar P; Drage LA; Martin DP
Mayo Clin Proc; 2009 Mar; 84(3):274-80. PubMed ID: 19252116
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
Li J; Fu L; Yang Y; Wang G; Zhao A
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455278
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
19. VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study.
Asada H
Vaccine; 2019 Oct; 37(44):6776-6781. PubMed ID: 31543415
[TBL] [Abstract][Full Text] [Related]
20. Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles.
Otani N; Shima M; Yamamoto T; Okuno T
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
